Medpace Holdings Inc Dossier
Qualitative Analysis
Business overview
Medpace Holdings, Inc. (NASDAQ: MEDP) is a leading global, scientifically-driven, full-service clinical contract research organization (CRO). Headquartered in Cincinnati, Ohio, the company provides Phase I-IV drug and medical device development services primarily to small and mid-sized biotechnology, pharmaceutical, and medical device industries. Medpace operates under a highly disciplined, fully integrated operating model, offering comprehensive services including clinical trial management, medical writing, biometrics, pharmacovigilance, and global central laboratory services. Unlike many larger peers, Medpace focuses heavily on emerging biotech sponsors, avoiding large pharmaceutical partnerships to maintain high-margin, high-science execution.
Research as of 19 Jun 2026
Strategic Initiatives
Growth programs, investments, and their expected impact
A multi-year, $150M+ physical expansion of the Cincinnati headquarters and bioanalytical laboratories scheduled through 2026 to handle complex biologics assays and increase sample throughput capacity.
Expected impact: Increases laboratory throughput, supports up to 1,500 new jobs, and enhances the service mix toward higher-margin, complex trials.
Adding and scaling regional offices in Tokyo, Seoul, and other APAC hubs to capture regional biotech growth and streamline regulatory submissions across local authorities.
Expected impact: Deepens patient access, expands global trial footprint, and captures market share in the fast-growing APAC clinical trials market.
Integrating machine learning and AI predictive models into Medpace's proprietary ClinTrak platform to optimize site selection and patient recruitment.
Mergers, Acquisitions & Partnerships
Recent deals and strategic collaborations
Strategic Partnerships
Medpace maintains a highly selective approach to collaboration, evaluating sponsors based on scientific alignment, regulatory plans, and financial strategies to act as a seamless extension of the sponsor team.
Terms: Typically structured as multi-year, full-service clinical development contracts